BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20603585)

  • 21. Successful chemotherapy for a case of therapy-related ALL with MLL gene rearrangement following treatment of breast cancer.
    Xie X; Zhang C; Liu M; Yao G; Tong L; Chen J; Huang C; Guo Z; Ye C
    Breast J; 2013; 19(4):451-2. PubMed ID: 23721514
    [No Abstract]   [Full Text] [Related]  

  • 22. Maternal acute lymphoctic leukemia with rearrangement of the mixed lineage leukemia gene occurring during pregnancy.
    Aljurf M; Nassar A; Saleh AJ; Almhareb F; Alzahrani H; Walter C; Bakr M; Ahmed SO; Chaudhri N
    Hematol Oncol Stem Cell Ther; 2009; 2(3):399-402. PubMed ID: 20139053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
    Tomita N; Fujita H; Koharazawa H; Maruta A; Kodama F; Yamamoto T; Kobayashi S; Okubo T
    Rinsho Ketsueki; 1997 Feb; 38(2):135-41. PubMed ID: 9059068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early onset of acute lymphoblastic leukemia with MLL rearrangement after autologous stem cell transplantation for multiple myeloma.
    Ueda K; Yamamoto G; Shinohara A; Hangaishi A; Kurokawa M
    Ann Hematol; 2009 Aug; 88(8):813-4. PubMed ID: 19127363
    [No Abstract]   [Full Text] [Related]  

  • 26. B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature.
    Sajaroff EO; Mansini A; Rubio P; Alonso CN; Gallego MS; Coccé MC; Eandi-Eberle S; Bernasconi AR; Ampatzidou M; Paterakis G; Papadhimitriou SI; Petrikkos L; Papadakis V; Polychronopoulou S; Rossi JG; Felice MS
    Leuk Lymphoma; 2016 Oct; 57(10):2289-97. PubMed ID: 26857438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination of interphase- and metaphase-fluorescence in situ hybridization to identify 11q23/MLL abnormalities in acute leukemia patients].
    Zhao XC; Li CW; Dai Y; Liu XP; Qin S; Liu SH; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):682-6. PubMed ID: 17343201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic conversion from t(8;21) acute myeloid leukemia to MLL gene rearrangement-positive acute lymphoblastic leukemia.
    Ohsaka A; Kato K; Hikiji K
    Hematopathol Mol Hematol; 1998; 11(3-4):185-92. PubMed ID: 9844825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia.
    Millot F; Brizard F; Sorel N; Preudhomme C; Cividin M; Guilhot F; Brizard A
    Leuk Lymphoma; 2005 Jun; 46(6):925-7. PubMed ID: 16019540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12).
    Brassesco MS; Valera ET; Meyer C; Marschalek R; Lopes BA; Queiroz RGP; Calado RT; Scrideli CA; Tone LG
    Cancer Genet; 2018 Dec; 228-229():110-114. PubMed ID: 30553463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
    Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not
    Zuo W; Wang SA; DiNardo C; Yabe M; Li S; Medeiros LJ; Tang G
    J Clin Pathol; 2017 Mar; 70(3):244-249. PubMed ID: 27496968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96).
    Isoyama K; Eguchi M; Hibi S; Kinukawa N; Ohkawa H; Kawasaki H; Kosaka Y; Oda T; Oda M; Okamura T; Nishimura S; Hayashi Y; Mori T; Imaizumi M; Mizutani S; Tsukimoto I; Kamada N; Ishii E
    Br J Haematol; 2002 Sep; 118(4):999-1010. PubMed ID: 12199778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy.
    Larish AM; Dolan M; Casey T; Perkins JL
    J Pediatr Hematol Oncol; 2015 May; 37(4):e215-7. PubMed ID: 25493458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
    Jansen MW; Corral L; van der Velden VH; Panzer-Grümayer R; Schrappe M; Schrauder A; Marschalek R; Meyer C; den Boer ML; Hop WJ; Valsecchi MG; Basso G; Biondi A; Pieters R; van Dongen JJ
    Leukemia; 2007 Apr; 21(4):633-41. PubMed ID: 17268512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
    Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
    Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
    Bergh J; Wiklund T; Erikstein B; Lidbrink E; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson NO; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Wilking N
    Lancet; 2000 Oct; 356(9239):1384-91. PubMed ID: 11052580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies.
    Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig WD; Grote W; Löffler H; Schlegelberger B
    Br J Haematol; 1996 Mar; 92(3):673-80. PubMed ID: 8616034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.